Literature DB >> 11853360

Neuropsychological impairment among manic, depressed, and mixed-episode inpatients with bipolar disorder.

Michael R Basso1, Natasha Lowery, Jackie Neel, Rod Purdie, Robert A Bornstein.   

Abstract

Previous research has demonstrated broad neurobehavioral abnormalities in bipolar affective disorder (cf. G. Cassens, L. Wolfe, & M. Zola, 1990). However, there have been no comparisons of neuropsychological function across patients with manic, depressed, or mixed subtypes. In the present study, 37 manic, 24 mixed-episode, and 25 depressed bipolar I inpatients and 34 control subjects were administered a brief battery of neuropsychological tests. The multivariate and univariate effects of participant group on the neuropsychological measures were uniformly significant (p < .05). Planned contrasts revealed that the bipolar participants performed worse than the controls, and few differences existed between the 3 patient groups. Additionally, the bipolar groups were impaired on 50% of the test battery. These abnormalities were unlikely attributable to differences in psychiatric symptomatology, medical illness, comorbid psychiatric diagnoses, or medication status. Findings imply that acute mood disturbance during bipolar disorder yields significant neurobehavioral dysfunction.

Entities:  

Mesh:

Year:  2002        PMID: 11853360     DOI: 10.1037//0894-4105.16.1.84

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  20 in total

1.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

Review 2.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

4.  Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  MedGenMed       Date:  2006-08-23

5.  Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

Authors:  Katherine E Burdick; Raphael J Braga; Charles U Nnadi; Yaniv Shaya; Walter H Stearns; Anil K Malhotra
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

6.  Cognitive deficits in bipolar disorder: from acute episode to remission.

Authors:  J Volkert; M A Schiele; Julia Kazmaier; Friederike Glaser; K C Zierhut; J Kopf; S Kittel-Schneider; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-26       Impact factor: 5.270

Review 7.  Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.

Authors:  Taiane Cardoso; Isabelle E Bauer; Thomas D Meyer; Flavio Kapczinski; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

8.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Authors:  Matthew M Kurtz; Raphael T Gerraty
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

Review 9.  Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.

Authors:  Katherine E Burdick; Raphael J Braga; Joseph F Goldberg; Anil K Malhotra
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Differential executive functioning performance by phase of bipolar disorder.

Authors:  Kelly A Ryan; Aaron C Vederman; E Michelle McFadden; Anne L Weldon; Masoud Kamali; Scott A Langenecker; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2012-08       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.